Silo Pharma (SILO) Competitors $0.75 -0.06 (-7.41%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SILO vs. PMNT, MGOL, EVKG, LULU, ONON, AS, BIRK, GIL, LEVI, and BRPShould you be buying Silo Pharma stock or one of its competitors? The main competitors of Silo Pharma include Perfect Moment (PMNT), MGO Global (MGOL), Ever-Glory International Group (EVKG), Lululemon Athletica (LULU), ON (ONON), Amer Sports (AS), Birkenstock (BIRK), Gildan Activewear (GIL), Levi Strauss & Co. (LEVI), and The Baldwin Insurance Group (BRP). These companies are all part of the "apparel" industry. Silo Pharma vs. Perfect Moment MGO Global Ever-Glory International Group Lululemon Athletica ON Amer Sports Birkenstock Gildan Activewear Levi Strauss & Co. The Baldwin Insurance Group Silo Pharma (NASDAQ:SILO) and Perfect Moment (NASDAQ:PMNT) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, risk, valuation, dividends, community ranking, analyst recommendations, earnings and institutional ownership. Which has better valuation & earnings, SILO or PMNT? Silo Pharma has higher earnings, but lower revenue than Perfect Moment. Perfect Moment is trading at a lower price-to-earnings ratio than Silo Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilo Pharma$72.10K46.64-$3.70M-$1.22-0.61Perfect Moment$21.31M0.63-$8.72M-$1.30-0.62 Does the MarketBeat Community favor SILO or PMNT? Silo Pharma and Perfect Moment both received 1 outperform votes by MarketBeat users. CompanyUnderperformOutperformSilo PharmaOutperform Votes1100.00% Underperform VotesNo VotesPerfect MomentOutperform Votes1100.00% Underperform VotesNo Votes Which has more risk and volatility, SILO or PMNT? Silo Pharma has a beta of 0.2, meaning that its share price is 80% less volatile than the S&P 500. Comparatively, Perfect Moment has a beta of -3.46, meaning that its share price is 446% less volatile than the S&P 500. Do institutionals and insiders hold more shares of SILO or PMNT? 5.6% of Silo Pharma shares are held by institutional investors. Comparatively, 23.0% of Perfect Moment shares are held by institutional investors. 4.4% of Silo Pharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to SILO or PMNT? In the previous week, Silo Pharma had 7 more articles in the media than Perfect Moment. MarketBeat recorded 8 mentions for Silo Pharma and 1 mentions for Perfect Moment. Silo Pharma's average media sentiment score of 0.35 beat Perfect Moment's score of 0.00 indicating that Silo Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Silo Pharma 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Perfect Moment 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate SILO or PMNT? Perfect Moment has a consensus price target of $6.00, suggesting a potential upside of 644.23%. Given Perfect Moment's stronger consensus rating and higher probable upside, analysts plainly believe Perfect Moment is more favorable than Silo Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Silo Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Perfect Moment 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SILO or PMNT more profitable? Perfect Moment has a net margin of -67.38% compared to Silo Pharma's net margin of -5,255.05%. Silo Pharma's return on equity of -61.38% beat Perfect Moment's return on equity.Company Net Margins Return on Equity Return on Assets Silo Pharma-5,255.05% -61.38% -47.49% Perfect Moment -67.38%-513.83%-119.38% SummarySilo Pharma beats Perfect Moment on 10 of the 16 factors compared between the two stocks. Get Silo Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for SILO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SILO vs. The Competition Export to ExcelMetricSilo PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.36M$6.90B$5.57B$7.82BDividend YieldN/A3.06%5.11%4.22%P/E Ratio-0.617.4422.4218.48Price / Sales46.64242.72394.10103.91Price / CashN/A65.8538.1834.62Price / Book0.356.516.774.25Net Income-$3.70M$143.21M$3.22B$248.23M7 Day Performance-35.35%3.95%3.25%3.29%1 Month Performance-40.00%0.34%0.01%2.42%1 Year Performance-59.19%2.58%18.00%5.54% Silo Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SILOSilo Pharma0.7445 of 5 stars$0.75-7.4%N/A-59.2%$3.63M$72,102.00-0.612News CoverageGap DownPMNTPerfect Moment1.2047 of 5 stars$0.93+0.5%$6.00+548.6%-72.2%$15.32M$21.31M-0.7131Gap DownMGOLMGO GlobalN/A$0.31-33.8%N/A-86.9%$894,000.00$5.20M-0.077Gap DownHigh Trading VolumeEVKGEver-Glory International GroupN/A$0.00flatN/A+0.0%$10,000.00N/A0.004,300LULULululemon Athletica4.5383 of 5 stars$260.71+2.7%$371.72+42.6%-24.9%$31.60B$10.59B18.9129,000Analyst ForecastShort Interest ↓Gap DownONONON3.8096 of 5 stars$42.31+2.4%$60.00+41.8%+51.5%$26.63B$2.32B98.361,160Analyst ForecastPositive NewsGap DownASAmer Sports4.0869 of 5 stars$21.98+1.5%$32.64+48.5%+69.7%$12.21B$5.18B-157.4511,400Analyst ForecastNews CoveragePositive NewsGap DownBIRKBirkenstock2.4317 of 5 stars$47.30+1.4%$67.50+42.7%+15.0%$8.87B$1.86B38.107,400Short Interest ↑GILGildan Activewear4.7883 of 5 stars$41.35+1.3%$60.00+45.1%+33.1%$6.27B$3.27B16.5451,000Earnings ReportDividend AnnouncementAnalyst UpgradeAnalyst RevisionNews CoveragePositive NewsLEVILevi Strauss & Co.3.7834 of 5 stars$15.28+1.7%$19.18+25.5%-24.6%$6.06B$6.40B29.4418,000Analyst UpgradeBRPThe Baldwin Insurance Group1.8325 of 5 stars$42.13-1.5%$37.00-12.2%+58.0%$4.95B$1.27B-45.799,200 Related Companies and Tools Related Companies Perfect Moment Competitors MGO Global Competitors Ever-Glory International Group Competitors Lululemon Athletica Competitors ON Competitors Amer Sports Competitors Birkenstock Competitors Gildan Activewear Competitors Levi Strauss & Co. Competitors The Baldwin Insurance Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SILO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silo Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silo Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.